Skoog I - Search Results

1

Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.

Blennow K, Wallin A, Gottfries CG, Lekman A, Karlsson I, Skoog I, Svennerholm L. Blennow K, et al. Among authors: skoog i. Neurobiol Aging. 1992 Jan-Feb;13(1):107-13. doi: 10.1016/0197-4580(92)90017-r. Neurobiol Aging. 1992. PMID: 1371850

2

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age.

Blennow K, Wallin A, Gottfries CG, Karlsson I, Månsson JE, Skoog I, Wikkelsö C, Svennerholm L. Blennow K, et al. Among authors: skoog i. Eur Neuropsychopharmacol. 1993 Mar;3(1):55-61. doi: 10.1016/0924-977x(93)90295-w. Eur Neuropsychopharmacol. 1993. PMID: 7682460

3

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Långström G, Skoog I, Svennerholm L, Wikkelsö C. Blennow K, et al. Among authors: skoog i. Eur Neurol. 1993;33(2):129-33. doi: 10.1159/000116919. Eur Neurol. 1993. PMID: 8467819

4

Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis.

Blennow K, Fredman P, Wallin A, Gottfries CG, Frey H, Pirttilä T, Skoog I, Wikkelsö C, Svennerholm L. Blennow K, et al. Among authors: skoog i. J Neurol Sci. 1994 Jan;121(1):90-6. doi: 10.1016/0022-510x(94)90161-9. J Neurol Sci. 1994. PMID: 8133315

5

Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production.

Blennow K, Fredman P, Wallin A, Gottfries CG, Skoog I, Wikkelsö C, Svennerholm L. Blennow K, et al. Among authors: skoog i. Eur Neurol. 1993;33(2):134-42. doi: 10.1159/000116920. Eur Neurol. 1993. PMID: 8467820

6

Immunoglobulin M in cerebrospinal fluid: reference values derived from 111 healthy individuals 18-88 years of age.

Blennow K, Skoog I, Wallin A, Wikkelsö C, Fredman P. Blennow K, et al. Among authors: skoog i. Eur Neurol. 1996;36(4):201-5. doi: 10.1159/000117248. Eur Neurol. 1996. PMID: 8814421

7

A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.

Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karlsson I, Gottfries CG, Blennow K. Skoog I, et al. Neurology. 1998 Apr;50(4):966-71. doi: 10.1212/wnl.50.4.966. Neurology. 1998. PMID: 9566380

8

Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.

Simonsen AH, McGuire J, Podust VN, Davies H, Minthon L, Skoog I, Andreasen N, Wallin A, Waldemar G, Blennow K. Simonsen AH, et al. Among authors: skoog i. Neurobiol Aging. 2008 Jul;29(7):961-8. doi: 10.1016/j.neurobiolaging.2007.01.011. Epub 2007 Feb 23. Neurobiol Aging. 2008. PMID: 17321007

9

No association of VEGF polymorphims with Alzheimer's disease.

Landgren S, Palmér MS, Skoog I, Minthon L, Wallin A, Andreasen N, Zetterberg M, Blennow K, Zetterberg H. Landgren S, et al. Among authors: skoog i. Neuromolecular Med. 2010 Sep;12(3):224-8. doi: 10.1007/s12017-009-8096-8. Epub 2009 Oct 20. Neuromolecular Med. 2010. PMID: 19842071

10

Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.

Skoog I, Hesse C, Fredman P, Andreasson LA, Palmertz B, Blennow K. Skoog I, et al. Arch Neurol. 1997 Mar;54(3):267-72. doi: 10.1001/archneur.1997.00550150029012. Arch Neurol. 1997. PMID: 9074395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters